Eder C. Pincinato
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CGE26-137: Association Between Genetic Ancestry and TPMT/NUDT15 Phenotypes in Patients From Brazil's Unified Health System (SUS).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
CGE26-137: Association Between Genetic Ancestry and TPMT/NUDT15 Phenotypes in Patients From Brazil's Unified Health System (SUS).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery.
Journal: Cell reports. Medicine
Published: February 15, 2025
Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field.
Journal: Biomarkers in medicine
Published: November 17, 2021
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
Journal: BMC cancer
Published: February 28, 2021
FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 07, 2020
GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Journal: Scientific reports
Published: October 27, 2018
Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients.
Journal: Oncotarget
Published: February 03, 2018
GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.
Journal: Basic & clinical pharmacology & toxicology
Published: April 18, 2017
XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Journal: Oncotarget
Published: October 30, 2015
Effects of High-Dose Cisplatin Chemotherapy and Conventional Radiotherapy on Urinary Oxidative and Nitrosative Stress Biomarkers in Patients with Head and Neck Cancer.
Journal: Basic & clinical pharmacology & toxicology
Published: April 25, 2015
Do genetic polymorphisms modulate response rate and toxicity of Cisplatin associated with radiotherapy in laryngeal squamous cell carcinoma?: a case report.
Journal: Medicine
Published: April 24, 2015
Last Updated: 09/26/2026